CIK 0001850270 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
PROKIDNEY CORP.
Sign in to watch- Ticker
- PROK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- EIN
- 981586514
- Phone
- 336-999-7028
- Business address
- 2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
- Former names
- Social Capital Suvretta Holdings Corp. III
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 8-K Event Regulation FD disclosure
- 4 Planned sale Chief Regulatory Officer sold 17,238 shares at $4.08 ($70,386)
- 144 Insider Sale of Securities
- 4 Open-market buy 10% owner bought 177,000 shares at an average $1.42 ($251,666)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 4 Planned sale SVP of Regulatory Development sold 17,238 shares at an average $2.51 ($43,343)
- 144 Insider Sale of Securities
- 4 Planned sale SVP of Regulatory Development sold 17,238 shares at $2.50 ($43,095)
- 4 Planned sale SVP of Regulatory Development sold 84,403 shares at an average $1.73 ($146,005)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 8 of 21 · 406 filings